Product Information
MOMETASONE FUROATE 0.1% OINT is a generic product labeled by Torrent Pharmaceuticals Limited, priced at $0.2926 per GM under NDC 13668052701. Its NADAC has been published 32 times since Jan 14, 2026.
FDA first approved this application on Jul 13, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Torrent Pharmaceuticals LimitedNDC
13668052701
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
MOMETASONE FUROATEApproval Type
Generic (ANDA)
FDA Application
ANDA207899FDA Approved
7/13/2018
TE Code
AB
On Market Since
12/15/2024
Pharmacological Classes
Price Statistics
The NADAC for MOMETASONE FUROATE 0.1% OINT has been published 32 times since Jan 14, 2026, and over the history we have for it it has declined 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2926 per GM |
|---|---|
| All-time high | $0.3226 (May 13, 2026) |
| All-time low | $0.2926 (Aug 19, 2026) |
| 52-week high | $0.3226 |
| 52-week low | $0.2926 |
| Median price | $0.3162 |
| Average price | $0.3130 |
| Largest weekly change | -4.5% (Jul 22, 2026) |
| Weeks tracked | 32 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 31% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MOMETASONE FUROATE 0.1% OINT?
The current National Average Drug Acquisition Cost (NADAC) for MOMETASONE FUROATE 0.1% OINT, manufactured by Torrent Pharmaceuticals Limited, is $0.2926 per GM (NDC 13668052701), effective Aug 19, 2026.
How has the price of MOMETASONE FUROATE 0.1% OINT changed over time?
Over the history we have for it, the NADAC for MOMETASONE FUROATE 0.1% OINT has declined 8.2%. It has been tracked across 32 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for MOMETASONE FUROATE 0.1% OINT?
Since Jan 14, 2026, the NADAC for MOMETASONE FUROATE 0.1% OINT has ranged from a low of $0.2926 (Aug 19, 2026) to a high of $0.3226 (May 13, 2026), with a median of $0.3162 per GM.
Are there cheaper alternatives to MOMETASONE FUROATE 0.1% OINT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MOMETASONE FUROATE 0.1% OINT, is $0.2029 per GM — about 31% below MOMETASONE FUROATE 0.1% OINT.
Who manufactures MOMETASONE FUROATE 0.1% OINT?
MOMETASONE FUROATE 0.1% OINT (NDC 13668052701) is labeled by Torrent Pharmaceuticals Limited, and CMS classifies it as a generic product.